Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (32)
NITAG documentation (1597)
Reports (56)
SAGE documentation (226)
Scientific publications (112)
Systematic reviews (SYSVAC) (2883)
Regions
Africa (278)
Americas (768)
Eastern Mediterranean (50)
Europe (708)
South-East Asia (81)
Western Pacific (207)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1523)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (159)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (72)
HIV / AIDS (10)
Human papillomavirus (HPV) (497)
Influenza (589)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (133)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (107)
Pneumococcal disease (281)
Poliomyelitis (86)
Q fever (1)
Rabies (30)
Rotavirus (117)
RSV (Respiratory syncytial virus) (52)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (78)
Typhoid (25)
Varicella (73)
Yellow fever (42)
Zika (1)
Show more
4906 results found
2023
∙
STIKO
Recommendations by the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute – 2023
2023
∙
ACIP
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season
2023
Routine vaccination programme against COVID-19 in the Netherlands
2023
Employee vaccination: tick-borne encephalitis in the Netherlands
2023
∙
NACI, Anne Pham-Huy, Joseline Zafack, Courtney Primeau, Oliver Baclic, Marina Salvadori, Shelley Deeks
A National Advisory Committee on Immunization (NACI) update on invasive meningococcal disease (IMD) epidemiology and program-relevant considerations for preventing IMD in individuals at high risk of exposure
2023
∙
ATAGI
ATAGI Update on the COVID-19 Vaccination Program
2023
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against RSV (adults) in Belgium
2023
∙
Magdalena Bastias, Louise Henaff, Christoph Steffen, Shalini Desai
Fifth GNN meeting record of discussion
2023
∙
ACIP
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices
2023
∙
ACIP
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register